BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31646441)

  • 1. Cost-effectiveness of proton therapy in treating base of skull chordoma.
    Austin AM; Douglass MJJ; Nguyen GT; Dalfsen R; Le H; Gorayski P; Tee H; Penniment M; Penfold SN
    Australas Phys Eng Sci Med; 2019 Dec; 42(4):1091-1098. PubMed ID: 31646441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
    Li G; Xia YF; Huang YX; Okat D; Qiu B; Doyen J; Bondiau PY; Benezery K; Gao J; Qian CN
    BMC Cancer; 2021 Aug; 21(1):944. PubMed ID: 34419008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
    Sher DJ; Tishler RB; Pham NL; Punglia RS
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):875-882. PubMed ID: 29976499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radiobiological Markov simulation tool for aiding decision making in proton therapy referral.
    Austin AM; Douglass MJJ; Nguyen GT; Penfold SN
    Phys Med; 2017 Dec; 44():72-82. PubMed ID: 29254594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
    Jones DA; Candio P; Shakir R; Ramroth J; Wolstenholme J; Gray AM; Cutter DJ; Ntentas G
    Clin Oncol (R Coll Radiol); 2023 May; 35(5):301-310. PubMed ID: 36732121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
    Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
    Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient selection for proton therapy: a radiobiological fuzzy Markov model incorporating robust plan analysis.
    Austin AM; Douglass MJJ; Nguyen GT; Penfold SN
    Phys Eng Sci Med; 2020 Jun; 43(2):493-503. PubMed ID: 32524433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013.
    Amin NP; Sher DJ; Konski AA
    Appl Health Econ Health Policy; 2014 Aug; 12(4):391-408. PubMed ID: 25022451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualised selection of left-sided breast cancer patients for proton therapy based on cost-effectiveness.
    Austin AM; Douglass MJJ; Nguyen GT; Cunningham L; Le H; Hu Y; Penfold SN
    J Med Radiat Sci; 2021 Mar; 68(1):44-51. PubMed ID: 32638527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour Volume and Dose Influence Outcome after Surgery and High-dose Photon Radiotherapy for Chordoma and Chondrosarcoma of the Skull Base and Spine.
    Gatfield ER; Noble DJ; Barnett GC; Early NY; Hoole ACF; Kirkby NF; Jefferies SJ; Burnet NG
    Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):243-253. PubMed ID: 29402600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skull base chordoma.
    Mendenhall WM; Mendenhall CM; Lewis SB; Villaret DB; Mendenhall NP
    Head Neck; 2005 Feb; 27(2):159-65. PubMed ID: 15641104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan.
    Hiroshima Y; Kondo M; Sawada T; Hoshi SL; Okubo R; Iizumi T; Numajiri H; Okumura T; Sakurai H
    Cancer Med; 2023 Oct; 12(20):20450-20458. PubMed ID: 37795771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma.
    Jäkel O; Land B; Combs SE; Schulz-Ertner D; Debus J
    Radiother Oncol; 2007 May; 83(2):133-8. PubMed ID: 17490770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton beam therapy for skull base chordomas: a systematic review of tumor control rates and survival rates.
    Pahwa B; Medani K; Lu VM; Elarjani T
    Neurosurg Rev; 2022 Dec; 45(6):3551-3563. PubMed ID: 36181614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of proton beam therapy for intraocular melanoma.
    Moriarty JP; Borah BJ; Foote RL; Pulido JS; Shah ND
    PLoS One; 2015; 10(5):e0127814. PubMed ID: 25993284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chordoma dedifferentiation after proton beam therapy: a case report and review of the literature.
    Frankl J; Grotepas C; Stea B; Lemole GM; Chiu A; Khan R
    J Med Case Rep; 2016 Oct; 10(1):280. PubMed ID: 27729085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Verma V; Mishra MV; Mehta MP
    Cancer; 2016 May; 122(10):1483-501. PubMed ID: 26828647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing Cost-Effective Allocation of Proton Therapy for Breast Irradiation.
    Mailhot Vega RB; Ishaq O; Raldow A; Perez CA; Jimenez R; Scherrer-Crosbie M; Bussiere M; Taghian A; Sher DJ; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):11-18. PubMed ID: 27084617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protons in head-and-neck cancer: bridging the gap of evidence.
    Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.